9th – 10th December 2025

The 2025 Weqas Annual POCT Conference took place in the Marriott Hotel, Cardiff on 9th and 10th December.

This two-day event focused on POCT EQA Interpretation, and POCT Applications, a “diagnostic anywhere” approach and innovation.

View 2025 Programme

• Presentations
• Posters
• Gallery

Day 1

Gareth Davies & Samantha Jones POCT EQA Report Interpretation

Download

---

Samantha Jones POCT EQA Case Studies

Download

---

Gareth Davies & Samantha Jones Weqas Connect Update

Unavailable

---

Samantha Jones Connectivity Updates

Download

---

Abbott Connectivity

Unavailable

---

Gareth Davies & Ceri Parfitt POCT Performance Update

Download

---

Day 2

Bernie Croal 10-year NHS Plan

Download

---

Katy Heaney Opportunities for high quality diagnostics in community

Download

---

Philip Turner Implementing IVDs in community healthcare: Challenges and Possible Solutions

Download

---

Sian Hilton POCT Pharmacogenomics, the PALOH-UK Study

Download

---

Eric Kilpatrick Clinical Utility of Ketone Testing

Download

---

Emma English POCT Haemoglobin A1c Performance

Download

---

Catherine Moore Use of Respiratory Virus POCT in ED, are we detecting current virus strains?

Download

---

Annette Thomas Evolving role of pharmacies

Download

---

Gareth Davies Future Developments

Download

Development of an External Quality Assessment (EQA) Programme for Point of Care (POCT) Respiratory Viruses

Performance Assessment of Point of Care Testing for Blood Glucose – a 5 Year Review

Accuracy of pO2 –a 20 year overview of blood gas performance

A Review of Lactate Performance on the Weqas Blood Gas External Quality Assessment (EQA) Programme – A comparison of POCT and Lab Instruments and their suitability for use in Sepsis Management

Use of Point of Care (POCT) C-Reactive Protein (CRP) to support antibiotic prescribing in primary care – Are they good enough? A Review of Performance on the Weqas POCT CRP Programme

Development of an External Quality Assurance Programme for a point-of-care test for phosphorylated insulin-like growth factor binding protein-1 (phIGFBP-1)

Analytical performance specifications (APS) – are we providing clinically appropriate APS for External Quality Assessment?

Weqas Problem Solving Algorithm – Troubleshooting Performance Issues; A Case Study

What do laboratories need from an External Quality Assessment (EQA) Programme – is it time to redefine the aims of EQA?